(A–D’), (F–F’), (H–H’), (K’) and (M–M’) Immunostaining of β-catenin with specific anti-amphioxus β-catenin antibody produced in the mouse. (J) Bright-field of the embryo shown with the signals in (J’…
(A-Aiii, B–Bi, C–Ci, D–Ev) or human ß-catenin (Bii-Biv). Overlay of double staining in Biv and Civ. Embryos are at the two-cell stage in A-Aiii, four-cell stage in B-Biv, 16-cell stage in C-Civ, …
Lateral view of the embryos in (A-Aiv), (B-Biv), (C-Civ), (D-Div), (E-Eeiv). The embryos are shown from the vegetal pole view in (A’-Aiv’), (B’-Biv’), (C’-Civ’). Blastopore view of the embryos in (D’…
(Aa-Abiv’) Double immunostaining of Gooosecoid and β-catenin. (Ba-Baiv’) Double immunostaining of P-Smad2 and β-catenin. Lateral view of embryos in (Aa-Aaiv), (Ab-Abiv), and (Ba-Baiv). The embryos …
(A) Commercial anti-phosphoSmad2 antibodies specifically label phospho-Smad2 (P-Smad2) in amphioxus. (B) Double immunostaining of Gooosecoid and P-Smad2. (C) Double immunostaining of P-Smad2 and …
The expression of Wnt/β-catenin target Axin, dorsal-specific genes Chordin and Goosecoid, dorsal-specific genes encoding signaling molecules Nodal and Vg1, dorsal-specific neural markers Neurogenin …
(A) The scheme illustrates the mechanism of Wnt/ß-catenin signaling inhibition by dnTcf. (B) mRNA expression of Chordin and Hex genes in the control embryos and embryos injected with dnTcf. (C) …
The expression of Axin, Chordin and Goosecoid in the control embryos and embryos treated with 5 µM of CHIR99021 at one-cell stage. Arrow in Ad marks ventral expansion of Chordin expression. …
(A) Expression of Brachyury and Elav proteins at the mid-neurula of amphioxus embryos injected with Wnt8 mRNA at a low dose (3 ng/µl) or high dose (7 ng/µl). (B–C) Expression of Brachyury and Elav …
(A) The embryos injected with mRNA of tdTomato alone. (B) and (C) The embryos injected with mRNA of tdTomato and Wnt8.
Double immunostaining detecting the protein expression of Brachyury and Ac-Tub in the embryos injected with a low (A) or high (B) dose of Wnt11 mRNA (50 ng/µl or 250 ng/µl, respectively). The insert …
(A) Expression of Nodal (Aa-av’’) and Goosecoid (Ab-bv’’) in the control embryos, which were treated with DMSO (Aa-a’’ and Ab-b’’), and the embryo treated with Wnt signaling inhibitor C59 (Aai-ai’’ …
Luciferase reporter plasmids containing cis-regulatory elements of amphioxus Goosecoid (A), Nodal and Vg1(B) were cotransfected with expression plasmid encoding a stabilized form of β-catenin …
(A) Wnt/β-catenin signaling determines the organizing center of the primary body axis formation in cnidarian Hydra and Nematostella. (A’) Wnt/β-catenin upstream of autoactivating Nodal signaling …
Reagent type (species) or resource | Designation | Source or reference | Identifiers | Additional information |
---|---|---|---|---|
Strain, strain background (Branchiostoma lanceolatum) | Wild type | collected in Argeles-sur-mer, France | NCBITaxon: 7740 | |
Strain, strain background (Branchiostoma floridae) | Wild type | Laboratory cultures, Institute of Molecular Genetics | NCBITaxon: 7739 | |
Chemical compound, drug | CHIR99021 | SelleckChem | S1263 | |
Chemical compound, drug | C59 | Xcess Bioscience Inc | M-60005–2 s | |
Chemical compound, drug | SB505124 | Sigma | S4696 | |
Antibody | Anti-β-Catenin, produced in rabbit | Sigma | C2206 | (1:500) |
Antibody | Anti-Smad2(phospho S255), produced in rabbit | Abcam | ab188334 | (1:20,000) |
Antibody | Anti-β-Catenin, produced in mouse | Bozzo et al., 2017 | (1:200) | |
Antibody | Anti-FoxA, produced in mouse | Bozzo et al., 2017 | (1:200) | |
Antibody | Anti-Goosecoid, produced in mouse | This paper | (1:200) | |
antibody | Anti-Brachyury, produced in mouse | This paper | (1:200) | |
Antibody | Anti-Elav, produced in mouse | This paper | (1:200) | |
Sequence-based reagent | Goosecoid_fw | This paper | GCTTCGGATCCGAAGTCACCGAGCGCACGACC | |
Sequence-based reagent | Goosecoid_rev | This paper | GGTCTAAGCTTACTGTCCGTCGCTAGGCGT | |
Sequence-based reagent | Brachyury_fw | This paper | GCTGTGGATCCGGAATGGAAGATTTGCAAGAT | |
Sequence-based reagent | Brachyury_rev | This paper | CCTGTAAGCTTAGAGCGATGGTGGAGTCAT | |
Sequence-based reagent | Elav_fw | This paper | GTGCTGGATCCGGCTCGCCCGACGGACGCAC | |
Sequence-based reagent | Elav_rev | This paper | GTGCTAAGCTTACAGTCCACTCACGTACAAGTT | |
Sequence-based reagent | Vg1_fw | This paper | GCGGCCACTGCTTTTACTTT | |
Sequence-based reagent | Vg1_rev | This paper | GTGTAGTAGTGGACAAGACTGAGGG | |
Sequence-based reagent | Nodal_fw | This paper | TAACGTGAGGCCAGGTGATG | |
Sequence-based reagent | Nodal_rev | This paper | CGGAGTTTGCGTGTTCGACT | |
Sequence-based reagent | Wnt8_fw | This paper | GGAATTCGCACGATGCTCGCACAGCTC | |
Sequence-based reagent | Wnt8_rev | This paper | GGAATTCCTAGTTGTTTCCCCTGTTTCTTC | |
Sequence-based reagent | Wnt11_fw | This paper | CTCTTCTTCAACCTGCGACTG | |
Sequence-based reagent | Wnt11_rev | This paper | TTTTCTCTGGCTTTCCCTTGA | |
Sequence-based reagent | dnTcf_fw | This paper | GCGATCTAGAGGTTCCAAGCCACCGTTGCAA | |
Sequence-based reagent | dnTcf_rev | This paper | GCTCAAGCTTTCACGTGTTGGGCGTTGACTT | |
Software, algorithm | Fiji | Schindelin et al., 2012 | ||
Software, algorithm | Leica Application Suite X (LAS X) | Leica |
Chemicals used in this study to affect the signaling pathways.